TITLE:
Clinical Study Of Schizophrenia in Both Men and Women

CONDITION:
Schizophrenia

INTERVENTION:
lamotrigine

SUMMARY:

      The objective of this study is to evaluate the effectiveness of a marketed drug in the
      treatment of schizophrenia, as an add-on therapy to antipsychotics over a 12-week period.
      Subjects with schizophrenia who have been maintained on a stable dose of antipsychotics and
      who fulfill the screening entrance criteria will have an assessment 1-7 days after the first
      visit to confirm eligibility.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion criteria:

          -  If female, must not be pregnant, or must be incapable of conceiving or be taking
             steps to prevent conception.

          -  Diagnosis of Schizophrenia

          -  Patients must be taking clozapine monotherapy or other atypical antipsychotic at
             least 3 months prior to this study.

        Exclusion criteria:

          -  Patients who are currently taking or have taken antidepressant medication in the last
             month prior.

          -  Patients who are or have been suicidal or homicidal in the last 6 months.

          -  Patients with a history of autistic disorder or another pervasive developmental
             disorder

          -  Patients whose condition is due to the direct physiological effects of a substance
             (e.g. a drug of abuse, a medication) or a general medical condition
      
